CJC1295/IPAMORELIN 10mg

CJC1295/IPAMORELIN 20mg combines two growth hormone-releasing peptides in a single formulation. CJC1295 is a GHRH analog designed to stimulate growth hormone release, while IPAMORELIN is a selective ghrelin mimetic that works synergistically to enhance GH secretion. This blend is commonly used in research settings to study growth hormone dynamics and metabolic responses. Typical research dosing ranges from 100–300 mcg per injection, administered via subcutaneous injection. The 20mg vial contains enough material for multiple doses depending on concentration and research protocol requirements. Store at 2–8°C when reconstituted for optimal stability. For research use only.

Intended for qualified life sciences professionals and institutional researchers only. Laboratory use only. Not for human consumption.